Brain tumours Flashcards
(43 cards)
How can brain tumours present? 4
Progressive motor deficit (68%)
Motor weakness (45%)
Headache 54%
Seizures 26%
Describe what symptoms are caused by a raised ICP?
headaches:
- worse in morning/awakening
- worse on coughing/leaning forward
- may be assoc. and get better with vomiting
Why can tumours cause raised ICP?
- tumour mass or oedema effect
- blockage of CSF flow
- haemorrhage
What would be the clinical features of a parietal lobe lesion?
sensory inattention apraxias astereognosis (tactile agnosia) inferior homonymous quadrantanopia Gerstmann's syndrome (lesion of dominant parietal): alexia, acalculia, finger agnosia and right-left disorientation
What would be the clinical features of a temporal lobe lesion?
Wernicke’s aphasia: unable to understand language
superior homonymous quadrantanopia
auditory agnosia
prosopagnosia (difficulty recognising faces)
What would be the clinical features of an occipital lobe lesion?
homonymous hemianopia (with macula sparing)
cortical blindness
visual agnosia
What would be the clinical features of a frontal lobe lesion?
expressive (Broca's) aphasia: located on the posterior aspect of the frontal lobe, in the inferior frontal gyrus. Speech is non-fluent, laboured, and halting disinhibition perseveration anosmia inability to generate a list
What would be the features of a cerebellar lesion?
midline lesions: gait and truncal ataxia
hemisphere lesions: intention tremor, past pointing, dysdiadokinesis, nystagmus
What is the most common type of brain tumour?
Astrocytic tumours
What is the WHO grading of astrocytic tumours?
I - pilocytic/pleomorphic xanthoastrocytoma/supependymal giant cell
II - low grade astrocytoma
III - anaplastic astrocytoma
IV - glioblastoma multiforme
(III and IV are malignant)
WHO I astrocytoma:
- benign or malignant?
- fast or slow growing?
- who is affected?
- where are these found?
- what is the treatment of choice?
Truly benign
Slow growing
Children, young adults
Pilocytic astrocytomas:
- optic nerve, hypothalamic gliomas - cerebellum, brainstem
Treatment of choice: surgery - curative
WHO II astrocytoma:
- where do these tend to occur?
- what is the presentation?
- what are poor prognostic factors?
Occur in the temporal/posterior frontal/anterior parietal
- presentation: siezures
- grow slowly but can transform into malignant neoplasms
what are poor prognostic factors for WHO II astrocytoma?
- age >50
- focal deficit
- short duration of symptoms
- raised ICP
- altered consciousness
- enhancement of contrast studies
What is the treatment of WHO II astrocytomas?
Surgery +/- one of below
- no treatment
- radiation
- chemo
- combined radio and chemo
What is the median survival of WHO III astrocytoma?
can arise de novo
- Median survival: 2 yrs
WHO IV
- is this common?
- what is the median survival?
- what is the spread?
- most common primary tumor
- Median survival: < 1yr
- spread: white matter tracking/ CSF pathways
What is the first line approach of brain tumours?
surgical
What are the three goals of surgery for brain tumour?
(i)to obtain a histological diagnosis
(ii) reduce the mass of the
tumour whilst preventing iatrogenic neurological deficit as effectively as possible and
(iii) to treat hydrocephalus if present.
-Surgery can be curative for most benign
tumours whilst debulking improves prognosis for malignant tumours provided the tumour is not infiltrating essential areas of the brain such as language areas
What chemotherapy is used for brain tumours?
- Temozolomide
- PCV
- Carmustine wafer
What is the role for radiotherapy in brain tumours? what are the skin effects?
Clear role in Malignant tumours post surgery
Low grade astrocytomas:
- incomplete removal
- malignant degeneration ( +/- surgery)
Benign astrocytomas:
-only if recurrence/ progression not amenable to surgery
Side effects:
–drops IQ by 10, skin, hair, tired
what novel therapies can be used for brain tumours?
immunotherapy
What is the second most common brain tumour?
oligodendroglial tumours
-20% of glial tumours
Oligodendroglial tumours:
- where do these occur?
- who is affected?
- what is the presentation?
- frontal lobes
- adults 25-45yrs (small peak in 6-12yrs)
- siezure presentation
Oligodenroglial tumours:
are these low or high grade?
low grade but can undergo malignant conversion